The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta‐analysis

Ähnliche Einträge

• Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis
  von: Tao Zhang, et al.
  Veröffentlicht: (2024)
• Systematic review and meta‐analysis: Impact of depression on prognosis in inflammatory bowel disease
  von: Yuejin Ji, et al.
  Veröffentlicht: (2024)
• Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease
  von: Alexis Bejcek, et al.
  Veröffentlicht: (2024)
• Prescribing in pregnant women with inflammatory bowel disease and its relationship to congenital malformations in Japan
  von: Sayumi Takahashi, et al.
  Veröffentlicht: (2024)
• Prevalence and etiologies of non‐responsive celiac disease: A systematic review and meta‐analysis
  von: Nishant Aggarwal, et al.
  Veröffentlicht: (2024)